COMMIT/CCS-2 (Clopidogrel and Metoprolol in Myocardial Infarction Trial/Second Chinese Cardiac Study)

COMMIT/CCS-2 (Clopidogrel and Metoprolol in Myocardial Infarction Trial/Second Chinese Cardiac Study)

Bibliographic Details
Main Author:	Chen, Z
Format:	Conference item
Published:	2005

Similar Items

COMMIT/CCS-2 Clopidogrel and Metoprolol in Myocardial Infarction Trial/Second Chinese Cardiac Study
by: Collins, R
Published: (2005)

Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
by: Second Chinese Cardiac Study (CCS-2) Collaborative Group
Published: (2000)

Clopidogrel and metoprolol in myocardial infarction - Reply
by: Chen, Z, et al.
Published: (2006)

Effect of early metoprolol on infarct size in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) trial
by: Suraj Khanal
Published: (2014-01-01)

COMMIT/CCS-2 studies - Authors' reply
by: Chen, Z, et al.
Published: (2006)

Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.
by: Chen, Z, et al.
Published: (2005)

ORAL CAPTOPRIL VERSUS PLACEBO AMONG 13634 PATIENTS WITH SUSPECTED ACUTE MYOCARDIAL-INFARCTION - INTERIM-REPORT FROM THE CHINESE CARDIAC STUDY (CCS-1)
by: Liu, L, et al.
Published: (1995)

Clopidogrel effectiveness in patients with ST elevation myocardial infarction
by: O. V. Sirotkina, et al.
Published: (2009-02-01)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction
by: Candice Volney, et al.
Published: (2019-07-01)

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
by: B. N. Garifullin, et al.
Published: (2016-01-01)

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
by: B. N. Garifullin, et al.
Published: (2016-01-01)

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.
by: Chen, Z, et al.
Published: (2005)

Gender difference in prognosis after acute MI among 45,852 Chinese patients in COMMIT/CCS2
by: Chen, Y, et al.
Published: (2009)

Acute myocardial infarction occurring while on chronic clopidogrel therapy ('clopidogrel failure') is associated with high incidence of clopidogrel poor responsiveness and stent thrombosis.
by: Ehud Regev, et al.
Published: (2018-01-01)

Ivabradine versus metoprolol in patients with acute inferior wall myocardial infarction – ‘Expanding arena for ivabradine’
by: R.K. Gokhroo, et al.
Published: (2015-12-01)

Ivabradine versus metoprolol in patients with acute inferior wall myocardial infarction – ‘Expanding arena for ivabradine’
by: Kumari Priti
Published: (2015-12-01)

Neutrophil stunning by metoprolol reduces infarct size
by: Jaime García-Prieto, et al.
Published: (2017-04-01)

Ticagrelor versus clopidogrel for recurrent myocardial infarction: An outcomes-based agreement
by: Samuel K. Peasah, et al.
Published: (2023-12-01)

Pilot experience with clopidogrel in the treatment of an .ST-elevation acute myocardial infarction
by: S V Shalaev, et al.
Published: (2004-06-01)

Assessment of clopidogrel on the left ventricular ejection fraction in acute myocardial infarction
by: Pejman Khosravi, et al.
Published: (2010-01-01)

To study the clopidogrel pharmacogenetics in north Indian population with acute myocardial infarction
by: R.K. Sinha, et al.
Published: (2017-11-01)

Modifying effect of diabetes on the short-term effect of clopidogrel in patients with myocardial infarction
by: Wuxiang Xie, et al.
Published: (2018-01-01)

Cost-effectiveness and cost–utility analysis of the use of clopidogrel and pantoprazole in comparison with clopidogrel and omeprazole for the secondary prevention of myocardial infarction in Iran
by: Mohammadreza Amirsadri, et al.
Published: (2021-01-01)

CLOPIDOGREL FOR SELECTIVE MYOCARDIAL REVASCULARIZATION
by: N. V. Teplova
Published: (2016-03-01)

Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Recurrent Stroke and Myocardial Infarction
by: Yong Kang Lee, et al.
Published: (2023-08-01)

Clopidogrel in the treatment of patients with ST-elevation acute myocardial infarction: state-of-art in 2013
by: O. V. Averkov
Published: (2013-02-01)

Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrel
by: Karla N. Samman, et al.
Published: (2021-06-01)

Efficacy and safety of ticagrelor versus clopidogrel in patients with non-ST-elevation myocardial infarction in Taiwan
by: Chih-Kuo Lee, et al.
Published: (2021-07-01)

Carvedilol and metoprolol are both able to preserve myocardial function in type 2 diabetes
by: Carol T. Bussey, et al.
Published: (2020-03-01)

Efficacy and Safety of Ticagrelor in Comparison to Clopidogrel in Elderly Patients With ST‐Segment–Elevation Myocardial Infarctions
by: Johannes Schmucker, et al.
Published: (2019-09-01)

Duration of clopidogrel treatment and risk of mortality and recurrent myocardial infarction among 11 680 patients with myocardial infarction treated with percutaneous coronary intervention: a cohort study
by: Køber Lars, et al.
Published: (2010-01-01)

Clopidogrel, ticagrelor, prasugrel or an alternation of two P2Y12 in patients with acute myocardial infarction with cardiogenic shock
by: Vojko Kanic, et al.
Published: (2024-01-01)

The effect of ticagrelor and clopidogrel on angiographic parameters according to diabetic status in patients with ST elevation myocardial infarction
by: F. Aydınyılmaz, et al.
Published: (2022-09-01)

Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention
by: Gianluca Campo, et al.
Published: (2017-10-01)

Dose-independent influence of metoprolol on cardiac and motor functions, QoL, and mental status in Chinese patients with CHF
by: Zhang Q, et al.
Published: (2018-12-01)

Effects of Metoprolol on Periprocedural Myocardial Infarction After Percutaneous Coronary Intervention (Type 4a MI): An Inverse Probability of Treatment Weighting Analysis
by: Duanbin Li, et al.
Published: (2021-11-01)

Outcomes According to Cardiac Catheterization Referral and Clopidogrel Use Among Medicare Patients With Non–ST‐Segment Elevation Myocardial Infarction Discharged Without In‐hospital Revascularization
by: Connie N. Hess, et al.
Published: (2016-03-01)

Clopidogrel effects on thrombolysis effectiveness and clinical course of ST elevation myocardial infarction (30-day follow-up)
by: S. V. Shalaev, et al.
Published: (2007-08-01)

Supplementation of Lipoic Acid, Zinc and Clopidogrel Reduces Mortality Rate and Incidence of Ventricular Arrhythmia in Experimental Myocardial Infarction
by: Enas Abdel-Hady, et al.
Published: (2021-03-01)

Effects of traditional Chinese exercises on cardiac rehabilitation in patients with myocardial infarction: a meta-analysis of randomized controlled trials
by: Jingfang Zhang, et al.
Published: (2023-10-01)